PHI with Biliary cirrhosis
How does this condition affect your private health insurance?
Zirrhose biliäre, more commonly known as Primary Biliary Cholangitis (PBC), is a chronic autoimmune liver disease. It involves the progressive destruction of small bile ducts within the liver. This damage leads to the accumulation of bile, causing inflammation and scarring (fibrosis). Over time, this scarring can develop into cirrhosis, liver failure, and necessitate a liver transplant. Key symptoms include profound fatigue, debilitating pruritus (itching), and later, jaundice. It's often diagnosed via elevated liver enzymes and specific antibodies. Treatment focuses on slowing disease progression and managing symptoms to improve quality of life.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Symptoms often emerge gradually over months or years, with initial complaints like fatigue or itching persisting indefinitely without treatment.
Duration of Illness (Lifetime)
Chronic and progressive, requiring lifelong management; can lead to end-stage liver disease if untreated.
Cost of Treatment (Initial)
Initial diagnostic workup and stabilization can range from $2,000 to $10,000, depending on testing and specialist consultations.
Cost of Treatment (Lifetime)
Tens of thousands to hundreds of thousands of dollars for medication and monitoring; potentially millions if a liver transplant is required.
Mortality Rate
Without effective treatment, the prognosis is poor, with high mortality rates. With early diagnosis and treatment (e.g., ursodeoxycholic acid), life expectancy significantly improves, approaching that of the general population for many, but still carries a risk of progression to liver failure and transplant-related mortality.
Risk of Secondary Damages
High. Common complications include portal hypertension, varices, ascites, hepatic encephalopathy, osteoporosis, fat-soluble vitamin deficiencies, and an increased risk of hepatocellular carcinoma. Significant psychological impact from chronic symptoms.
Probability of Full Recovery
Very low. PBC is a chronic, progressive disease with no known cure. Treatment aims to halt or slow disease progression and manage symptoms, not to achieve a complete recovery.
Underlying Disease Risk
Moderate to high. PBC is an autoimmune disease and is frequently associated with other autoimmune conditions, such as Sjögren's syndrome, rheumatoid arthritis, autoimmune thyroid disease, and scleroderma.